M&T Bank’s Minerva Neurosciences NERV Stock Holding History

M&T Bank’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,077	Closed	-$289K	–	1732
2016 Q4	$289K	Sell	3,077 -1,557	-34%	-$159K	﹤0.01%	1300
2016 Q3	$523K	Buy	4,634 +1,451	+46%	+$141K	﹤0.01%	1030
2016 Q2	$260K	Buy	+3,183	New	+$202K	﹤0.01%	1328

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

M&T Bank's NERV Position: Q1 2017 in Review

M&T Bank sold out of Minerva Neurosciences (NERV) in Q1 2017, closing a stake of 3,077 shares — an estimated $289K sold.

M&T Bank first reported a position in NERV in Q2 2016 and held it in 3 quarters. The position peaked at $523K in Q3 2016. 71 funds tracked by Wall St. Rank hold NERV as of Q1 2017.

M&T Bank reported no remaining Minerva Neurosciences position as of Q1 2017 after selling out during the quarter.
M&T Bank sold 3,077 Minerva Neurosciences shares in Q1 2017, an estimated $289K.
M&T Bank first reported a position in Minerva Neurosciences in Q2 2016 and held it in 3 quarters.
M&T Bank's Minerva Neurosciences position peaked at $523K in Q3 2016.
71 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2017.

Based on M&T Bank's 13F filing for Q1 2017, filed 10 May 2017.